Media headlines about China Biologic Products (NASDAQ:CBPO) have been trending somewhat positive recently, according to Accern. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. China Biologic Products earned a coverage optimism score of 0.20 on Accern’s scale. Accern also gave media coverage about the biopharmaceutical company an impact score of 46.0227878782486 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Separately, Zacks Investment Research upgraded China Biologic Products from a “sell” rating to a “hold” rating in a research note on Wednesday, November 15th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $137.50.

Shares of China Biologic Products (NASDAQ:CBPO) opened at $74.41 on Friday. China Biologic Products has a 12 month low of $72.21 and a 12 month high of $120.46. The firm has a market capitalization of $2,100.52, a P/E ratio of 16.94, a price-to-earnings-growth ratio of 1.24 and a beta of 1.78.

WARNING: This piece of content was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/somewhat-favorable-press-coverage-somewhat-unlikely-to-impact-china-biologic-products-cbpo-share-price/1764664.html.

China Biologic Products Company Profile

Insider Buying and Selling by Quarter for China Biologic Products (NASDAQ:CBPO)

Receive News & Ratings for China Biologic Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Biologic Products and related companies with MarketBeat.com's FREE daily email newsletter.